Skip to main content

Hemophilia Care in the New Millennium

  • Book
  • © 2001

Overview

Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 489)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (12 chapters)

  1. Infectious Disease Risk

  2. Unexplained Aspects of Hemophilia and Hemostasis

  3. Novel Approaches to Therapy

  4. Inhibitor Development in Hemophilia Patients

Keywords

About this book

There should be, and in the best of cases there is, a synergy between basic research and patient care. However, this synergy is hard to develop because the techniques required to be a successful researcher are so different from the skills required to be an outstanding physician. Harold R. Roberts, M.D., of the University of North Carolina at Chapel Hill, is an example of a physician-researcher who has benefited from having his feet in both the world of patient care and the world of the laboratory: he has let clinical problems direct his basic research effort and conversely has adopted research advances in his care of patients. Dr. Roberts's long and continuing career has included many research and clinical advances. He was part of the first group to determine the amino acid sequence of the important thrombin inhibitor hirudin and part of the group that prepared the first cryoprecipitates which were the first alternative to plasma as therapy in hemophilia A. Dr. Roberts has made significant advances in understanding the protein chemistry behind hemophilia B; he was among the first researchers to identify some patients as not being completely deficient but instead as having measurable levels of protein and subsequently demonstrated that this protein was dysfunctional. This important advance led him to a classification scheme for patients into Cross Reacting Material (CRM) positive, negative, and reduced. Dr.

Editors and Affiliations

  • University of North Carolina School of Medicine, Chapel Hill, USA

    Dougald M. Monroe, Gilbert C. White

  • Novo Nordisk A/S, Målov, Denmark

    Ulla Hedner

  • University of Lund, Lund, Sweden

    Ulla Hedner

  • Duke University and Durham VA Medical Centers, Durham, USA

    Maureane R. Hoffman

  • Hôpital Edouard Herriot, Lyon, France

    Claude Negrier

  • Guys’ and St. Thomas’s Trust, London, UK

    Geoffrey F. Savidge

Bibliographic Information

  • Book Title: Hemophilia Care in the New Millennium

  • Editors: Dougald M. Monroe, Ulla Hedner, Maureane R. Hoffman, Claude Negrier, Geoffrey F. Savidge, Gilbert C. White

  • Series Title: Advances in Experimental Medicine and Biology

  • DOI: https://doi.org/10.1007/978-1-4615-1277-6

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 2001

  • Hardcover ISBN: 978-0-306-46521-5Published: 31 March 2001

  • Softcover ISBN: 978-1-4613-5474-1Published: 24 September 2012

  • eBook ISBN: 978-1-4615-1277-6Published: 06 December 2012

  • Series ISSN: 0065-2598

  • Series E-ISSN: 2214-8019

  • Edition Number: 1

  • Number of Pages: XIV, 182

  • Topics: Internal Medicine, Hematology

Publish with us